# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001070081-25-000007
Filing Date
2025-01-13
Accepted
2025-01-13 14:00:25
Documents
47
Period of Report
2025-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | tmb-20250113x8k.htm iXBRL | 8-K | 50655
2 | EX-99.1 | tmb-20250113xex99d1.htm | EX-99.1 | 57647
3 | EX-99.2 | tmb-20250113xex99d2.htm | EX-99.2 | 39513
4 | GRAPHIC | tmb-20250113xex99d2g001.jpg | GRAPHIC | 112697
5 | GRAPHIC | tmb-20250113xex99d2g002.jpg | GRAPHIC | 19380
6 | GRAPHIC | tmb-20250113xex99d2g003.jpg | GRAPHIC | 42007
7 | GRAPHIC | tmb-20250113xex99d2g004.jpg | GRAPHIC | 360127
8 | GRAPHIC | tmb-20250113xex99d2g005.jpg | GRAPHIC | 94980
9 | GRAPHIC | tmb-20250113xex99d2g006.jpg | GRAPHIC | 99768
10 | GRAPHIC | tmb-20250113xex99d2g007.jpg | GRAPHIC | 97383
11 | GRAPHIC | tmb-20250113xex99d2g008.jpg | GRAPHIC | 107872
12 | GRAPHIC | tmb-20250113xex99d2g009.jpg | GRAPHIC | 99775
13 | GRAPHIC | tmb-20250113xex99d2g010.jpg | GRAPHIC | 97584
14 | GRAPHIC | tmb-20250113xex99d2g011.jpg | GRAPHIC | 114036
15 | GRAPHIC | tmb-20250113xex99d2g012.jpg | GRAPHIC | 69111
16 | GRAPHIC | tmb-20250113xex99d2g013.jpg | GRAPHIC | 145303
17 | GRAPHIC | tmb-20250113xex99d2g014.jpg | GRAPHIC | 172193
18 | GRAPHIC | tmb-20250113xex99d2g015.jpg | GRAPHIC | 113127
19 | GRAPHIC | tmb-20250113xex99d2g016.jpg | GRAPHIC | 105241
20 | GRAPHIC | tmb-20250113xex99d2g017.jpg | GRAPHIC | 80326
21 | GRAPHIC | tmb-20250113xex99d2g018.jpg | GRAPHIC | 134510
22 | GRAPHIC | tmb-20250113xex99d2g019.jpg | GRAPHIC | 151443
23 | GRAPHIC | tmb-20250113xex99d2g020.jpg | GRAPHIC | 138724
24 | GRAPHIC | tmb-20250113xex99d2g021.jpg | GRAPHIC | 85311
25 | GRAPHIC | tmb-20250113xex99d2g022.jpg | GRAPHIC | 118042
26 | GRAPHIC | tmb-20250113xex99d2g023.jpg | GRAPHIC | 120372
27 | GRAPHIC | tmb-20250113xex99d2g024.jpg | GRAPHIC | 123109
28 | GRAPHIC | tmb-20250113xex99d2g025.jpg | GRAPHIC | 129748
29 | GRAPHIC | tmb-20250113xex99d2g026.jpg | GRAPHIC | 137198
30 | GRAPHIC | tmb-20250113xex99d2g027.jpg | GRAPHIC | 145328
31 | GRAPHIC | tmb-20250113xex99d2g028.jpg | GRAPHIC | 89737
32 | GRAPHIC | tmb-20250113xex99d2g029.jpg | GRAPHIC | 19380
33 | GRAPHIC | tmb-20250113xex99d2g030.jpg | GRAPHIC | 42007
34 | GRAPHIC | tmb-20250113xex99d2g031.jpg | GRAPHIC | 42573
| Complete submission text file | 0001070081-25-000007.txt |  | 4981618

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
35 | EX-101.SCH | tmb-20250113.xsd | EX-101.SCH | 3974
36 | EX-101.DEF | tmb-20250113_def.xml | EX-101.DEF | 2805
37 | EX-101.LAB | tmb-20250113_lab.xml | EX-101.LAB | 16546
38 | EX-101.PRE | tmb-20250113_pre.xml | EX-101.PRE | 9654
49 | EXTRACTED XBRL INSTANCE DOCUMENT | tmb-20250113x8k_htm.xml | XML | 4679

Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 25525850
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)